November 16, 2023

Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium

November 16, 2023

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

November 14, 2023

Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

November 08, 2023

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

November 07, 2023

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

November 07, 2023

Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

October 31, 2023

Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications

October 10, 2023

Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8

August 09, 2023

Surmodics to Participate in Upcoming Investor Conferences in August

August 02, 2023

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

July 12, 2023

Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2

June 20, 2023

Surmodics Receives FDA Approval for the SurVeil™ Drug-Coated Balloon

June 14, 2023

Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System

May 25, 2023

Surmodics to Participate in the Jefferies Healthcare Conference on June 8

April 26, 2023

Surmodics Reports Second Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

April 20, 2023

Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System

April 19, 2023

Surmodics to Report Second Quarter of Fiscal 2023 Financial Results on April 26

April 19, 2023

Surmodics Announces Successful First Patient Use of Sublime™ Radial Access Microcatheter Designed for the Periphery

April 11, 2023

Surmodics to Participate in the 22nd Annual Needham Virtual Healthcare Conference on April 20

March 28, 2023

Surmodics Provides Regulatory Update on its Strategy to Submit an Amended Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

March 08, 2023

Surmodics to Participate in Upcoming Investor Conferences in March

February 06, 2023

Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

January 31, 2023

Surmodics to Host Virtual Annual Meeting of Shareholders

January 26, 2023

Surmodics to Report First Quarter of Fiscal 2023 Financial Results on February 6

January 19, 2023

Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference

January 19, 2023

Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon

January 16, 2023

Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18

November 17, 2022

Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium

November 11, 2022

Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16

November 09, 2022

Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance

November 02, 2022

24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference

October 28, 2022

Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th

October 26, 2022

Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022

October 17, 2022

Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing

October 11, 2022

6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe

October 07, 2022

6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe

August 23, 2022

Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022

July 27, 2022

Surmodics Reports Third Quarter Fiscal 2022 Results

July 19, 2022

Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27

April 27, 2022

Surmodics Reports Second Quarter Fiscal 2022 Results

April 27, 2022

Pounce™ Thrombectomy System First-in-Human Data Show 100 Percent Technical Success in Early Cases

April 25, 2022

Dr. Gary Ansel to Present Pounce™ Thrombectomy System First-in-Human Data at Charing Cross Symposium

April 19, 2022

Surmodics to Webcast Second Quarter Fiscal 2022 Earnings Conference Call on April 27

February 04, 2022

Surmodics to Host Virtual Annual Meeting of Shareholders

February 03, 2022

Surmodics Reports First Quarter Fiscal 2022 Results

January 26, 2022

Surmodics to Webcast First Quarter Fiscal 2022 Earnings Conference Call on February 3

January 11, 2022

Surmodics to Present at Sidoti & Company Virtual Investor Conference

November 10, 2021

Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance

November 02, 2021

Surmodics to Webcast Fourth Quarter Fiscal 2021 Earnings Conference Call on November 10

September 29, 2021

Surmodics Announces Successful First Patient Uses of Sublime™ Radial Access .018 RX PTA Dilatation Catheter